Discontinuation of Effient (Prasugrel) Before Spinal Procedures
Effient (prasugrel) must be discontinued at least 7 days before any spinal procedure to minimize the risk of catastrophic epidural hematoma and permanent neurological injury. 1, 2
Primary Recommendation
- The FDA drug label explicitly states that prasugrel should be stopped at least 7 days (1 week) prior to any surgery when possible 2
- The American College of Cardiology and American Heart Association consistently recommend the 7-day discontinuation window for all surgical procedures, with particular emphasis on spinal procedures due to their high bleeding risk 3, 1
- This 7-day period allows adequate recovery of platelet function, as prasugrel causes irreversible platelet inhibition for the entire platelet lifespan 1
Why Spinal Procedures Require Special Caution
- Spinal procedures are classified as high-bleeding risk procedures due to the potential for epidural or spinal hematoma in a closed anatomical space 1
- Bleeding in the spinal canal can result in permanent neurological injury, paralysis, or death 1
- The confined space of the spinal canal means even small amounts of bleeding can cause catastrophic compression of neural structures 1
High-Risk Patient Considerations
For patients with recent coronary stents, elective spinal surgery should ideally be postponed until the mandatory dual antiplatelet therapy duration is complete:
- Bare metal stents: Wait at least 6 weeks post-placement before considering elective spinal surgery 1
- Drug-eluting stents: Wait at least 6 months post-placement before considering elective spinal surgery 1
- This approach avoids the competing risks of stent thrombosis versus catastrophic spinal bleeding 1
If spinal surgery cannot be delayed in high-risk cardiac patients:
- Consultation with cardiology is mandatory before discontinuing prasugrel 1
- Consider bridging with short-acting antiplatelet agents like cangrelor (which can be stopped just 3 hours before the procedure) in select cases, though this requires specialized expertise 4
- The risk of stent thrombosis, myocardial infarction, and death increases significantly when prasugrel is stopped prematurely 2
Verification of Adequate Discontinuation
- The 7-day discontinuation period corresponds to approximately 4-5 half-lives of prasugrel's active metabolite, ensuring minimal residual antiplatelet effect 1
- Unlike some anticoagulants, there is no routine laboratory test to verify adequate platelet function recovery before spinal procedures 5
- Clinical assessment of bleeding risk and strict adherence to the 7-day window is the standard approach 1, 2
Resumption After Spinal Procedure
Prasugrel should be resumed 48-72 hours (2-3 days) post-operatively after spinal procedures:
- This delayed resumption allows adequate time for hemostasis and wound healing in high-bleeding risk procedures 1
- The prescribing physician must verify adequate hemostasis before restarting prasugrel 1
- For patients at very high thrombotic risk, consider starting with a reduced dose (150 mg once daily) for the first 1-2 days, then advancing to full dose (10 mg daily) 3
Critical Warnings
- Do not start prasugrel in patients likely to undergo urgent spinal surgery 2
- Patients must inform all physicians and dentists they are taking prasugrel before any invasive procedure is scheduled 2
- The physician performing the spinal procedure must communicate with the prescribing cardiologist before stopping prasugrel 2
- Stopping prasugrel without medical supervision significantly increases the risk of stent thrombosis, myocardial infarction, and death 2
Additional Bleeding Risk Factors
The following factors further increase bleeding risk and require heightened vigilance: